Dipeptidyl peptidase IV in tumor progression

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Dipeptidyl peptidase IV (DPPIV) is a glycoprotein implicated in various human malignancies.
• DPPIV's role in ovarian carcinoma progression requires further elucidation.

Purpose of the Study:

• To investigate the functional role of DPPIV in ovarian carcinoma cell invasion and peritoneal dissemination.
• To explore the molecular mechanisms underlying DPPIV's effect on ovarian carcinoma progression.

Main Methods:

• Ovarian carcinoma cell lines with varying DPPIV expression were analyzed.
• DPPIV cDNA was introduced into low-DPPIV expressing cells (SKOV3).
• In vitro migration, invasion assays, and in vivo peritoneal dissemination models in nude mice were employed.

Main Results:

• Higher DPPIV expression correlated with reduced invasive potential and migration in ovarian carcinoma cells.
• DPPIV transfection into SKOV3 cells significantly decreased cell migration, invasion, and peritoneal dissemination in vivo, leading to longer survival.
• DPPIV expression positively correlated with E-cadherin and was associated with a shift towards an epithelial phenotype.
• DPPIV transfection reduced matrix metalloproteinase 2 (MMP-2) and membrane type 1 matrix metalloprotease (MT1-MMP) while enhancing tissue inhibitors of matrix metalloproteinases (TIMPs).

Conclusions:

• DPPIV acts as a suppressor of ovarian carcinoma cell invasion and peritoneal dissemination.
• DPPIV regulates key molecules involved in cell invasion, including E-cadherin, MMPs, and TIMPs.
• DPPIV holds potential as a therapeutic target for reducing ovarian carcinoma progression and metastasis.